Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death
New England Journal of Medicine · 29.05.2025 · 392 (20) · 1987-2000
DOI: 10.1056/nejmoa2415160 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 29.05.2025. Verfasst von Marc Humbert und 22 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, INSERM Unité Mixte de Recherche en Santé 999, Hypertension Pulmonaire, Physiopathologie et Innovation Thérapeutique, Service…. Hauptthemen laut MEDLINE: Pulmonary Arterial Hypertension, Recombinant Fusion Proteins. Die Arbeit wurde bisher 181-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Merck.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université Paris-Saclay, INSERM Unité Mixte de Recherche en Santé 999, Hypertension Pulmonaire, Physiopathologie et Innovation Thérapeutique, Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre (Ass…
- Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor.
- Pulmonary Hypertension Program, University of Colorado, Anschutz Medical Campus, Aurora.
- Department of Internal Medicine, Justus-Liebig University Giessen, Universities of Giessen and Marburg Lung Center and Institute for Lung Health, Members of the German Center for Lung Research, Giessen, Germany.
- National Heart and Lung Institute, Imperial College London, London.
- Division of Cardiovascular Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC.
ORCID-Profile: Marc Humbert, Vallerie V McLaughlin, H Ardeschir Ghofrani, J Simon R Gibbs, Mardi Gomberg-Maitland, Ioana R Preston, Rogerio Souza, Aaron B Waxman, Victor M Moles, Laurent Savale, Carmine Dario Vizza, Stephan Rosenkranz, Samuel S Kim, Maria José Loureiro, Joerg Koglin, Marius M Hoeper
Förderung
- Merck
Zitieren
APA
Humbert, M., McLaughlin, V. V., Badesch, D. B., Ghofrani, H. A., Gibbs, J. S. R., Gomberg-Maitland, M., Preston, I. R., Souza, R., Waxman, A. B., Moles, V. M., Savale, L., Vizza, C. D., Rosenkranz, S., Shi, Y., Miller, B., Mackenzie, H. S., Kim, S. S., Loureiro, M. J., Patel, M. J., …, & ZENITH Trial Investigators (2025). Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death. New England Journal of Medicine, 392(20), 1987-2000. https://doi.org/10.1056/nejmoa2415160
Vancouver
Humbert M, McLaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, et al. Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death. New England Journal of Medicine. 2025;392(20):1987-2000. doi:10.1056/nejmoa2415160
BibTeX
@article{Humbert2025,
author = {Humbert, Marc and McLaughlin, Vallerie V and Badesch, David B and Ghofrani, H Ardeschir and Gibbs, J Simon R and Gomberg-Maitland, Mardi and Preston, Ioana R and Souza, Rogerio and Waxman, Aaron B and Moles, Victor M and Savale, Laurent and Vizza, Carmine Dario and Rosenkranz, Stephan and Shi, Yaru and Miller, Barry and Mackenzie, Harald S and Kim, Samuel S and Loureiro, Maria José and Patel, Mahesh J and Koglin, Joerg and Cornell, Alexandra G and Hoeper, Marius M and ZENITH Trial Investigators, ZENITH Trial Investigators},
title = {Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {20},
pages = {1987--2000},
doi = {10.1056/nejmoa2415160}
}
EUVIMED